Please use this identifier to cite or link to this item:
|Title:||Asian outpatients with schizophrenia: A double-blind randomized comparison of quality of life and clinical outcomes for patients treated with olanzapine or haloperidol|
Haroon Rashid Chaudhry
Syed Baqar Raza
Cynthia R. Leynes
Inam Ur Rehman Khan
Hasanah Che Ismail
Joy C. Ignacio
Sonia C. Rodriguez
Amanda J. Lowry
Alan J.M. Brnabic
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Cebu Doctors Hospital
Fatima Jinnah Medical College
St. Luke's Medical Center Quezon City
KV S.I.T.E. Hospital
School of Medical Sciences - Universiti Sains Malaysia
Jose R. Reyes Memorial Medical Center
Eli Lilly Australia Pty Ltd.
Eli Lilly (Philippines), Inc.
|Citation:||Journal of the Medical Association of Thailand. Vol.89, No.8 (2006), 1157-1170|
|Abstract:||To examine the quality of life (QoL) and clinical outcomes for Asian schizophrenic outpatients treated with olanzapine or haloperidol. Patients were randomized to 24-weeks' treatment with either olanzapine (n = 144) or haloperidol (n = 132) in a double-blind, prospective, multi-country study. The QLS and WHO-BREF were assessed for QoL; the PANSS, BPRS and CGI scales for clinical status; the BAS, AIMS and SAS scales for physical dysfunction. Regardless of antipsychotic, QoL improved significantly at 8 weeks and maintained this improvement at 24 weeks. Compared with haloperidol, olanzapine treatment was associated with significantly better QoL in the WHO-BREF physical and social relationship domains, better improvements in extrapyramidal symptoms in BAS and SAS scores, as well as lower incidence of adverse events. Patients taking haloperidol were more likely to be co-prescribed anticholinergics. The comparatively superior side-effect profile and tolerability of olanzapine may have contributed to enhance domain-specific QoL for these Asian outpatients.|
|Appears in Collections:||Scopus 2006-2010|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.